Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 2/20 | 0.36 |
| ▸ | PAM | P19021 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7219057 | 0.78 | ALDH1A1 (0.44) | FBP1ALDH1A1TSHRAKR1C3CYP3A4 | |
| SCHEMBL433428 | 0.78 | ALDH1A1 (0.44) | FBP1ALDH1A1TSHRAKR1C3CYP3A4 | |
| SCHEMBL9296651 | 0.76 | FBP1 (0.45) | FBP1ALDH1A1TSHRAKR1C3CYP3A4 | |
| SCHEMBL4631913 | 0.76 | FBP1 (0.45) | FBP1ALDH1A1TSHRAKR1C3CYP3A4 | |
| SCHEMBL4631911 | 0.76 | FBP1 (0.45) | FBP1ALDH1A1TSHRAKR1C3CYP3A4 | |
| SCHEMBL12735533 | 0.76 | FBP1 (0.45) | FBP1ALDH1A1TSHRAKR1C3CYP3A4 | |
| SCHEMBL627745 | 0.75 | TSHR (0.45) | FBP1ALDH1A1TSHRAKR1C3KDM1A | |
| SCHEMBL7731176 | 0.75 | FBP1 (0.41) | FBP1ALDH1A1TSHRAKR1C3CYP3A4 | |
| SCHEMBL10533493 | 0.75 | ALDH1A1 (0.41) | FBP1ALDH1A1TSHRAKR1C3CYP3A4 | |
| SCHEMBL4911765 | 0.75 | ALDH1A1 (0.41) | FBP1ALDH1A1TSHRAKR1C3CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6353070-B1 | STAR POLYMER OBTAINED BY POLYMERIZING VINYLAROMATIC MONOMER AND BRANCHING MONOMER CONTAINING AT LEAST TWO VINYLAROMATIC RADICALS IN PRESENCE OF CATALYST COMPRISING TRANSITION METAL COMPLEX, CATION-FORMING AGENT, OPTIONAL ALUMINUM COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-05 | — | — | US | disclosed |
| US-6303806-B2 | TITANIUM COMPOUNDS AS BRANCHING MONOMER UNITS | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-16 | — | — | US | disclosed |
| US-20010009966-A1 | Star polymers, and their preparation | WUNSCH JOSEF (DE) | 2001-07-26 | — | — | US | disclosed |
| US-6235838-B1 | USING STYRENE/DIPHENYLETHYLENE-DIENE BLOCK COPOLYMERS AS DISPERSING AUXILIARIES. | BASF AKTIENGESELLSCHAFT (DE) | 2001-05-22 | — | — | US | disclosed |
| US-4049596-A | Corrosion resistant aqueous and solvent-based primer compositions containing synergistic blends of zinc borate and barium metaborate pigments | PPG INDUSTRIES, INC. (US) | 1977-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010009966-A1 | Star polymers, and their preparation | MYB, PICALM, VMA21 | FBP1 3646/4885ALDH1A1 4099/4885TSHR 4464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.